MORGAN STANLEY PLC/CALL/AMGEN/330/0.1/20.09.24 | Market Closed - Börse Stuttgart 11:59:29 28/06/2024 pm IST | ||
| 0.79 EUR | -.--% |
|
| Current month | +29.85% | ||
| 1 month | +26.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 0.87 | +10.13% |
| 27/24/27 | 0.79 | -9.20% |
| 26/24/26 | 0.87 | -13.86% |
| 25/24/25 | 1.01 | +10.99% |
| 24/24/24 | 0.91 | +26.39% |
Delayed Quote Börse Stuttgart
Last update June 28, 2024 at 11:59 pm IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | MB0BQF |
| ISIN | DE000MB0BQF5 |
| Date issued | 09/11/2022 |
| Strike | 330 $ |
| Maturity | 20/09/2024 (82 Days) |
| Parity | 10 : 1 |
| Emission price | 3.02 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.24 € |
|---|---|
| Lowest since issue | 0.164 € |
| Delta | 0.36x |
| Omega | 13.03 |
| Premium | 8.38x |
| Gearing | 36.24x |
| Moneyness | 0.9468 |
| Difference Strike | 17.55 $ |
| Difference Strike % | +5.32% |
| Spread | 0.03 € |
| Spread % | 3.66% |
| Theoretical value | 0.8050 |
| Implied Volatility | 25.03 % |
| Total Loss Probability | 68.19 % |
| Intrinsic value | 0.000000 |
| Present value | 0.8050 |
| Break even | 338.62 € |
| Theta | -0.06x |
| Vega | 0.05x |
| Rho | 0.02x |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Warrants
- Warrant
